Marketing and Licensing Agreements
Medtronic Announces Strategic Agreement with OsteoGenix, Incorporated
Published in Drug Law Weekly, April 3rd, 2007
Medtronic, Inc. (NYSE:MDT) announced it has entered into a development agreement with OsteoGenix Incorporated, a privately-held orthobiologic pharmaceutical company based in California. The agreement will enable OsteoGenix to complete preclinical work on its proprietary bone anabolic agent and advance this program through clinical trials. The agreement will give Medtronic an additional source of bone growth therapies for surgeons whose patients require bone grafting options.
"We welcome the agreement announced," said Pete Wehrly, senior vice president and president of the Spinal and Navigation businesses at Medtronic. "We see OsteoGenix as bringing a new option to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2007-04-03)
More Articles from Drug Law Weekly
- Alcoholism
New alcoholism study findings recently were published by researchers at RTI International - Cancer Vaccines
Geron Corporation Reports Fourth Quarter And Annual 2006 Financial Results And Highlights - Cancer Vaccines
IMS Health Reports Global Pharmaceutical Market Grew 7.0 Percent in 2006, to $643 Billion - Drug Development
Teva Provides Update on Generic Celebrex Litigation - Drug Resistance
Studies from University of Chicago reveal new findings on drug resistance - DUSA Pharmaceuticals
Dusa Pharmaceuticals Reports Fourth-quarter And Year-end 2006 Financial Results - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
